Weaker Buy Today FOLD ranks #2469 as BUY CANDIDATE. Stronger Buy
Today FOLD ranks #2469 as BUY CANDIDATE.

FOLD stock Amicus Therapeutics

FOLD stock
Amicus Therapeutics

February 15, 2019
Change 1.87%
Chart period: 2018-11-16 - 2019-02-15
VOLUME
Buy
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Will FOLD stock price go up or down on Tue, 19 Feb 2019?

Amicus Therapeutics Forecast and Stock Analysis

Technical FOLD stock analysis for February 15, 2019.

Buy candidate since 2019-02-15
Shorts n/a
Cash n/a
Loans n/a
Beta 1.84
ROA -44.98

Amicus Therapeutics gained 1.87% in the last trading day, rising from $11.21 to $11.42 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a -5.46% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 1.21 million more shares were traded than the day before. In total, 3.09 million shares bought and sold for approximately $35.27 million.

Close price at the end of the last trading day (Friday, 15th Feb 2019) of the FOLD stock was $11.42. This is 1.87% more than the trading day before Thursday, 14th Feb 2019.

During day the stock fluctuated 4.91% from a day low at $11.20 to a day high of $11.75.

30 day high of the FOLD stock price was $12.49 and low was $10.30.
90 day high was $12.49 and low was $8.27.
52 week high for the Amicus Therapeutics - $17.62 and low - $8.27.

Trend

Amicus Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 15.24% during the next 3 months and, with 90% probability hold a price between $10.86 and $14.81 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Amicus Therapeutics holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $11.23 and $11.29. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday February 11, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 53 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Amicus Therapeutics finds support from accumulated volume at $11.14.

Support: $11.14 Price: $11.42 Resistance: $11.67

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.55 (4.91%) between high and low. For the last week, the stock has had a daily average volatility of 3.35%.

Our recommended stoploss: $10.84 (-5.05%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 4 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Buy Candidate

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.

Weaker Buy Today FOLD ranks #2469 as BUY CANDIDATE. Stronger Buy
Today FOLD ranks #2469 as BUY CANDIDATE.